uniQure (QURE)
(Delayed Data from NSDQ)
$4.72 USD
-0.04 (-0.84%)
Updated May 28, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
uniQure N.V. [QURE]
Reports for Purchase
Showing records 121 - 140 ( 153 total )
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Biotechnology: 2H15 Catalysts For Key Stocks From Our Research Universe
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
GT for Parkinson''s Shaping Up to Be an Intriguing Datapoint
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Compelling Entry Point Heading to Data Readouts
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Recent Pullback Offers Attractive Entry Points Ahead of Key Data
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Not All Gene Therapies Are Created Alike
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
1Q15 Update: Progressing on Many Fronts; Reiterate Buy Rating and PT $39
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: LIN C
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Sanfilippo, Hemophilia B, and Parkinson''s Data Over the Next Nine Months
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Prepping for Sanfilippo Data During 3Q15
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
Targeting CNS-disorders With AAVs, Currently Under the Radar
Provider: Roth Capital Partners, Inc.
Analyst: CHATTOPADHYAY D
Company: uniQure N.V.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.